Treatment adherence and use of complementary and alternative medicine in patients with infl ammatory bowel disease;A terápiás adherencia, valamint a komplementer és alternatív gyógymódok használata gyulladásos bélbetegek kezelésében

Orvosi Hetilap

Volumn 151, Issue 7, 2010, Pages 250-258

  Lakatos, László ^a   Czeglédi, Zsófia ^b   Dávid, Gyula ^a   Kispál, Zsófi ^g   Kiss, Lajos S ^g   Palatka, Károly ^c   Kristóf, Tünde ^d   Molnár, Tamás ^e   Salamon, Ágnes ^b   Demeter, Pál ^f   Miheller, Pál ^g   Szamosi, Tamás ^b   Banai, János ^b   Papp, Mária ^c   Bene, László ^h   Kovács, Ágota ^h   Rácz, István ^b   Lakatos, Péter László ^g  

^a Belgyogyaszati Centrum   (Hungary)

^b Gasztroenterológiai Osztály ^*  (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d Borsod Abauj Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz   (Hungary)

^e UNIVERSITY OF SZEGED   (Hungary)

^f ST JOHN'S HOSPITAL   (Hungary)

^g SEMMELWEIS UNIVERSITY   (Hungary)

^h Peterfy Sandor Utcai Korhaz   (Hungary)

Author keywords

Adherence; Complementary medicine; Crohn s disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ACUPUNCTURE; ADULT; ALTERNATIVE MEDICINE; ARTICLE; CROHN DISEASE; DEMOGRAPHY; DISEASE DURATION; DOCTOR PATIENT RELATION; ENTERITIS; FEMALE; GROUPS BY AGE; HERBAL MEDICINE; HOMEOPATHY; HUMAN; HUNGARY; IMMUNOSUPPRESSIVE TREATMENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT EDUCATION; PILL; PRESCRIPTION; PREVALENCE; PSYCHIATRIC TREATMENT; QUESTIONNAIRE; SEX DIFFERENCE; ULCERATIVE COLITIS;

ADRENAL CORTEX HORMONES; ADULT; AGED; COLITIS, ULCERATIVE; COMPLEMENTARY THERAPIES; CROHN DISEASE; EDUCATIONAL STATUS; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; URBAN POPULATION;

EID: 76949089564     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2010.28805     Document Type: Article

References (31)

1. Kane, S. V., Brixner, D., Rubin, D. T. es mtsa: The challenge of compliance and persistence: focus on ulcerative colitis. J. Manag. Care Pharm., 2008, 14 (Suppl. a), S2-S12.
2. Horne, R., Weinman, J.: Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J. Psychosom. Res., 1999, 47, 555-567.
3. Kruk, M. E., Schwalbe, N.: The relation between intermittent dosing and adherence: Preliminary insights. Clin. Ther., 2006, 26, 1989-1995.
4. Kane, S. V., Huo, D., Aikens, J. es mtsa: Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am. J. Med., 2003, 114, 39-43.
5. Kane, S. V., Cohen, R. D., Aikens, J. E. es mtsa: Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am. J. Gastroenterol., 2001, 96, 2929-2933.
6. Rubin, G., Hungin, A. P., Chinn, D. es mtsai: Long-term aminosalicylate therapy is under-used in patients with ulcerative colitis: a cross-sectional survey. Aliment Pharmacol. Ther., 2002, 16, 1889-1893.
7. Bernal, I., Domenech, E., Garcia-Planella, E. es mtsai: Medication- taking behaviour in a cohort of patients with infl ammatory bowel disease. Dig. Dis. Sci., 2006, 51, 2165-2169.
8. Beardon, P. H., McGilchrist, M. M., McKendrick, A. D. es mtsai: Primary non-compliance with prescribed medication in primary care. BMJ, 1993, 307, 846-848.
9. Robinson, A.: Review article: improving adherence to medication in patients with infl ammatory bowel disease. Aliment. Pharmacol. Ther., 2008, 27 (Suppl. 1), 9-14.
10. Cerveny, P., Bortlik, M., Kubena, A. es mtsai: Nonadherence in infl ammatory bowel disease: results of factor analysis. Infl amm. Bowel Dis., 2007, 13, 1244-1249.
11. Baars, J. E., Zelinkova, Z., Markus, T. es mtsai: High level of adherence to therapy in Dutch patients with infl ammatory bowel disease. Gut, 2007, 56 (Suppl. III), A146.
12. Ediger, J. P., Walker, J. R., Graff, L. es mtsai: Predictors of medication adherence in infl ammatory bowel disease. Am. J. Gastroenterol., 2007, 102, 1417-1426.
13. Bokemeyer, B., Teml, A., Roggel, C. es mtsai: Adherence to thiopurine treatment in out-patients with Crohn's disease. Aliment. Pharmacol. Ther., 2007, 26, 217-225.
14. Kane, S., Dixon, L.: Adherence rates with infl iximab therapy in Crohn's disease. Aliment. Pharmacol. Ther., 2006, 24, 1099-1103.
15. Sewitch, M. J., Abrahamowicz, M., Barkun, A. es mtsai: Patient nonadherence to medication in infl ammatory bowel disease. Am. J. Gastroenterol., 2003, 98, 1535-1544.
16. D'Inca, R., Bertomoro, P., Mazzocco, K. es mtsai: Risk factors for non-adherence to medication in infl ammatory bowel disease patients. Aliment. Pharmacol. Ther., 2008, 27, 166-172.
17. Mantzaris, G. J., Roussos, A., Kalantzis, C. es mtsai: How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission? Infl amm. Bowel Dis., 2007, 13, 446-450.
18. Shale, M. J., Riley, S. A.: Studies of compliance with delayed-release mesalazine therapy in patients with infl ammatory bowel disease. Aliment. Pharmacol. Ther., 2003, 18, 191-198.
19. Langmead, L., Rampton, D. S.: Review article: complementary and alternative therapies for infl ammatory bowel disease. Aliment. Pharmacol. Ther., 2006, 23, 341-349.
20. Smart, H. L., Mayberry, J. F., Atkinson, M.: Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut, 1986, 27, 826-828.
21. Rawsthorne, P., Shanahan, F., Cronin, N. C. es mtsai: An international survey of the use and attitudes regarding alternative medicine by patients with infl ammatory bowel disease. Am. J. Gastroenterol., 1999, 94, 1298-1303.
22. Hilsden, R. J., Verhoef, M. J., Best, A. es mtsa: Complementary and alternative medicine use by Canadian patients with infl ammatory bowel disease: results from a national survey. Am. J. Gastroenterol., 2003, 98, 1563-1568.
23. Eisenberg, D. M., Kessler, R. C., Foster, C. es mtsai: Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N. Engl. J. Med., 1993, 328, 246-252.
24. Li, F. X., Verhoef, M. J., Best, A. es mtsai: Why patients with infl ammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey. Can. J. Gastroenterol., 2005, 19, 567-573.
25. Lennard-Jones, J. E.: Classification of infl ammatory bowel disease. Scand. J. Gastroenterol., 1989, 24 (Suppl. 170), 2-6.
26. Silverberg, M. S., Satsangi, J., Ahmad, T. es mtsai: Toward an integrated clinical, molecular and serological classification of infl ammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol., 2005, 19 (Suppl. A), 5-36.
27. Greenley, R. N., Stephens, M., Doughty, A. es mtsai: Barriers to adherence among adolescents with infl ammatory bowel disease. Infl amm. Bowel Dis., 2010, 16, 36-41 (Published online 11 May 2009).
28. Hommel, K. A., Davis, C. M., Baldassano, R. N.: Objective versus subjective assessment of oral medication adherence in pediatric infl ammatory bowel disease. Infl amm. Bowel Dis., 2009, 15, 589-593.
29. Belaiche, J., Desager, J. P., Horsmans, Y. es mtsa: Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease. Scand. J. Gastroenterol., 2001, 36, 71-76.
30. Joos, S., Rosemann, T., Szecsenyi, J. es mtsai: Use of complementary and alternative medicine in Germany - a survey of patients with infl ammatory bowel disease. BMC Complement. Altern. Med., 2006, 6, 19.
31. Burgmann, T., Rawsthorne, P., Bernstein, C. N.: Predictors of alternative and complementary medicine use in infl ammatory bowel disease: do measures of conventional health care utilization relate to use? Am. J. Gastroenterol., 2004, 99, 889-893.